H. Itoh et al. / Bioorg. Med. Chem. 10 (2002) 4029–4034
4033
C H N OCl Si: C, 52.48; H, 5.87; N, 8.16. Found: C,
1
J=7.6 Hz), 1.75(1H, dt, J=7.6, 14.3 Hz), 1.90 (1H, dt,
J=7.6, 14.3 Hz), 4.37 (1H, d, J=14.3 Hz), 4.45(1H, d,
J=14.3 Hz), 7.00 (2H, t, J=8.7 Hz), 7.28 (2H, dd,
J=5.3, 8.7 Hz), 7.84 (1H, s), 7.88 (1H, s). MS m/z: 235
5
20
2
2
5
2.48; H, 5.60; N, 8.26.
2-(2,4-Difluorophenyl)-1-(imidazol-1-yl)-3-trimethylsilyl-
propan-2-ol (8d). Mp 147–148 C. IR (KBr) cm : 3122,
ꢀ
957, 2900, 1620, 1596, 1515, 1499, 1431, 1415, 1283,
271, 1247, 1231, 1130, 1094, 1078. H NMR (200 MHz,
À1
+
(M ), 206, 164, 123, 109. Anal. calcd for C H FN O:
1
2
14
3
2
1
C, 61.26; H, 6.00; N, 17.86. Found: C, 61.41; H, 5.97; N,
17.71.
1
CDCl ) d: À0.19 (9H, s), 1.12 (1H, d, J=15.0 Hz), 1.64
3
(1H, d, J=15.0 Hz), 4.19 (1H, d, J=14.2 Hz), 4.31 (1H,
d, J=14.2 Hz), 6.742–6.89 (4H, m), 7.38–7.50 (2H, m).
2-(4-Fluorophenyl)-4-methyl-1-(1H-1,2,4-triazol-1-yl)pen-
ꢀ
À1
tan-2-ol (9c). Mp 126–129 C. IR (KBr) cm : 3190,
2958, 2873, 1606, 1512, 1425, 1357, 1224, 1207, 1141,
+
MS m/z: 310 (M ), 295, 229, 131 Anal. calcd for
C H F N OSi: C, 58.04; H, 6.49; N, 9.02. Found: C,
1
1031. H NMR (200 MHz, CDCl ) d: 0.68 (3H, d,
1
5
20
2
2
3
5
8.02; H, 6.44; N, 9.19.
J=6.3 Hz), 0.92 (3H, d, J=6.3 Hz), 1.53–1.70 (2H, m),
1.80–1.88 (1H, m), 4.04 (1H, s), 4.31 (1H, d,
1-(Imidazol-1-yl)-2-pheny-3-trimethylsilylpropan-2-ol (8e).
Mp 178–179 C. IR (KBr) cm : 2957, 2707, 1596,
1
J=14.0 Hz), 4.40 (1H, d, J=14.0 Hz), 6.99 (2H, t,
J=8.5Hz), 7.31 (2H, dd, J=5.5, 8.5 Hz), 7.79 (1H, s),
ꢀ
511, 1443, 1407, 1343, 1283, 1247, 1190, 1108, 1078. H
À1
1
+
7.89 (1H, s). MS m/z: 263 (M ), 206, 181, 164, 139, 121,
109. Anal. calcd for C H FN O: C, 63.86; H, 6.89; N,
15.96. Found: C, 63.90; H, 6.87; N, 15.70.
NMR (200 MHz, CDCl ) d: À0.20 (9H, s), 1.19 (1H, d,
3
14 18
3
J=14.7 Hz), 1.42 (1H, d, J=14.7 Hz), 4.09 (1H, d,
J=14.0 Hz), 4.17 (1H, d, J=14.0 Hz), 6.64 (1H, s), 6.90
(
(
1H, s), 7.23 (1H, s), 7.29–7.35( 5H , m). MS m/z: 275
+
4,4-Dimethyl-2-(4-fluorophenyl)-1-(1H-1,2,4-triazol-1-yl)
pentan-2-ol (9d). Mp 129–133 C. IR (KBr) cm : 3184,
ꢀ
2954, 2858, 1604, 1515, 1361, 1277, 1209, 1143, 1124,
À1
M ), 259, 193, 185, 103. Anal. calcd for C H N OSi:
1
5
22
2
C, 65.65; H, 8.08; N, 10.21. Found: C, 65.61; H, 8.11; N,
1
1
0.23.
1022. H NMR (200 MHz, CDCl ) d: 0.79 (9H, s), 1.72
3
(1H, d, J=14.5Hz), 1.95(1H, d, J=14.5Hz), 4.14 (1H,
1
-(Imidazol-1-yl)-2-(4-methylphenyl)-3-trimethylsilyl-
ꢀ
s), 4.27 (1H, d, J=13.7 Hz), 4.38 (1H, d, J=13.7 Hz),
6.96 (2H, t, J=6.8 Hz), 7.32 (2H, dd, J=7.5, 8.8 Hz),
À1
propan-2-ol (8f). Mp 172–173 C. IR (KBr) cm : 3144,
956, 1511, 1428, 1400, 1283, 1244, 1111, 1078. 1
+
2
H
7.73 (1H, s), 7.87 (1H, s). MS m/z: 277 (M ), 206, 195,
164, 139, 123, 109. Anal. calcd for C H FN O: C,
NMR (200 MHz, CDCl ) d: À0.19 (9H, s), 1.17 (1H, d,
3
15 20
3
J=14.7 Hz), 1.41 (1H, d, J=14.7 Hz), 2.34 (3H, s), 4.06
(
64.96; H, 7.27; N, 15.15. Found: C, 64.87; H, 7.23; N,
14.93.
1H, d, J=15.0 Hz), 4.14 (1H, d, J=15.0 Hz), 6.67 (1H, s),
+
6
.93 (1H, s), 7.11–7.22 (5H, m). MS m/z: 288 (M ), 273,
07, 199, 117. Anal. calcd for C H N OSi: C, 66.62;
2
H, 8.39; N, 9.71. Found: C, 66.88; H, 8.14; N, 9.84.
2-(4-Fluorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol (9b).
1
6
24
2
ꢀ
À1
Mp 94–95 C. IR (KBr) cm : 3178, 2921, 2864, 1604,
510, 1461, 1427, 1276, 1220, 1136, 1089, 1031. 1
NMR (200 MHz, CDCl ) d: 0.82 (3H, t, J=7.0 Hz),
1
H
3
General procedure for the Grignard reaction in the
presence of magnesium bromide diethyl etherate
1.04 (1H, m), 1.15–1.32 (3H, m), 1.68 (1H, m), 1.83 (1H,
m), 4.00 (1H, s), 4.36 (1H, d, J=14.3 Hz), 4.44 (1H, d,
J=14.3 Hz), 6.99 (2H, t, J=7.7 Hz), 7.30 (2H, dd,
J=3.5, 7.7 Hz), 7.83 (1H, s), 7.87 (1H, s). MS m/z: 263
A
(
solution of (1H-1,2,4-triazol-1-yl)acetophenone
1.5mmol) in dichloromethane (2.0 mL) was added to a
suspension of magnesium bromide diethyl etherate
775mg, 3.0 mmol) in dichloromethane (3.0 mL) and
diethyl ether (3 mL) at room temperature and stirred for
.5h. A solution of trimethylsilylmethylmagnesium
+
(M ), 206, 191, 164, 149, 138, 123, 109. Anal. calcd for
C H FN O: C, 63.86; H, 6.89; N, 15.96. Found: C,
63.80; H, 6.80; N, 15.93.
(
1
4
18
3
0
chloride (1.5M) in diethyl ether (2.0 mL, 3.0 mmol) was
ꢀ
Silicon-containing azole derivatives (1a–1j) were
obtained in the same way. The yields are given in Table 2.
added at 0 C. After stirring for 0.5h, the mixture was
poured into ice, quenched with an aqueous solution of
ammonium chloride, and extracted with ethyl acetate.
The organic layer was washed with water and dried over
magnesium sulfate. The solvent was then evaporated,
and the solid remaining was partitioned between toluene
and 1 N HCl. The organic layer was washed with water
and concentrated to yield a residue, and this residue was
purified by chromatography and crystallized from diiso-
propyl ether. The yields are given in Table 3.
Antifungal activity
Four-millimeter mycelial agar discs were placed on
potato dextrose agar plates containing test compounds.
The plates were incubated at 25 C for 7 days as for a
test of P. oryzae or 3 days as for a test of R. solani, and
the diameters of the mycelium colonies were then mea-
sured to examine the effects of the chemicals on fungal
growth. The results are shown in Table 4.
ꢀ
The same general method was used to prepare the deri-
vatives described below.
Curative activity against rice blast
2
-(4-Fluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
Rice seedlings (variety Sachikaze) at the 4–5leaf stage
were sprayed with a spore suspension of the fungus P.
oryzae and kept in a moist chamber (relative humidity:
ꢀ
931, 1602, 1521, 1460, 1415, 1286, 1217, 1163, 1134,
À1
(
9a). Mp 94–96 C. IR (KBr) cm : 3205, 3110, 2970,
2
1
1
ꢀ
099, 1016. H NMR (200 MHz, CDCl ) d: 0.80 (3H, t,
100%) at 20–22 C. After 24 h, the rice seedlings were
3